Abstract | BACKGROUND: FINDINGS: CONCLUSIONS: The effects of D2-ag on VEGF translation and secretion are mediated by D2 signaling pathways that have yet to be described. We found that D2-ag inhibits VEGF secretion at the post-transcriptional level, suggesting that D2-ag treatment should be combined with therapies that inhibit VEGF transcription, such as the employment of LH or GnRH for triggering ovulation, to improve the efficacy of OHSS prevention.
|
Authors | Hortensia Ferrero, Carmen M García-Pascual, Nuria Pellicer, Carlos Simón, Antonio Pellicer, Raúl Gómez |
Journal | Reproductive biology and endocrinology : RB&E
(Reprod Biol Endocrinol)
Vol. 13
Pg. 104
(Sep 17 2015)
ISSN: 1477-7827 [Electronic] England |
PMID | 26377185
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DRD2 protein, human
- Dopamine Agonists
- Ergolines
- Receptors, Dopamine D2
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Cabergoline
|
Topics |
- Adult
- Cabergoline
- Dopamine Agonists
(pharmacology)
- Ergolines
(pharmacology)
- Female
- Granulosa Cells
(drug effects, metabolism)
- Humans
- Receptors, Dopamine D2
(agonists, metabolism)
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors, biosynthesis, metabolism)
|